FRANKLIN, MA: Echo Therapeutics, a medical device and specialty pharmaceuticals company, has retained Hayden IR as it nears the completion of two new products: Prelude SkinPrep, a skin permeation platform technology, and Symphony tCGM, a needle-free glucose monitoring system. The firm will develop an IR campaign promoting Echo's strategic vision, reputation, and competitive strengths.
Echo Therapeutics retains Hayden IR
FRANKLIN, MA: Echo Therapeutics, a medical device and specialty pharmaceuticals company, has retained Hayden IR as it nears the completion of two new products.
